Literature DB >> 27357554

Cardiovascular Fitness and Neurocognitive Performance among Older Adults in the Maintenance Stage of Cardiac Rehabilitation.

Yael Netz1, Tzvi Dwolatzky2, Abid Khaskia3, Ayelet Dunsky1.   

Abstract

BACKGROUND: Cardiovascular fitness is associated with cognition in advanced age. Cardiovascular disease (CVD) is a risk factor for cognitive decline beyond the normal aging process, thus we investigated this association in CVD patients.
METHOD: Patients in phase III of cardiac rehabilitation were divided into high and low cardiovascular fitness groups based on their predicted peak VO2. Cognition was assessed by a battery of neuropsychological tests examining memory, attention, visual spatial function, executive function and global cognitive score.
RESULTS: The two groups were similar on reported physical activity and on the Mini-Mental State Examination (MMSE). However, the high fitness group had significantly higher scores than the lower fitness group on attention and on the global cognitive score, and marginally significant scores on executive functioning. LIMITATION: Due to the small sample size no differentiation was made among the various CVD conditions.
CONCLUSION: Higher cardiovascular fitness of CVD patients is associated with superior cognition - predominantly in attention and executive functioning.

Entities:  

Mesh:

Year:  2015        PMID: 27357554

Source DB:  PubMed          Journal:  Isr J Psychiatry Relat Sci        ISSN: 0333-7308            Impact factor:   0.481


  2 in total

1.  Factors Associated With Cardiac Rehabilitation Participation in Older Adults After Myocardial Infarction: THE SILVER-AMI STUDY.

Authors:  David W Goldstein; Alexandra M Hajduk; Xuemei Song; Sui Tsang; Mary Geda; John A Dodson; Daniel E Forman; Harlan Krumholz; Sarwat I Chaudhry
Journal:  J Cardiopulm Rehabil Prev       Date:  2022-03-01       Impact factor: 2.081

2.  The effects of a resistance vs. an aerobic single session on attention and executive functioning in adults.

Authors:  Ayelet Dunsky; Mona Abu-Rukun; Sharon Tsuk; Tzvi Dwolatzky; Rafi Carasso; Yael Netz
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.